Last reviewed · How we verify

NCT05347537

Effects of Mulligan's Mobilization With and Without Clamshell Exercises in Sacroiliac Joint Dysfunction

Completed NA Last updated 9 November 2022
What this trial tests

NA trial testing Mulligan mobilization in Sacroiliac Joint Somatic Dysfunction in 36 participants. Completed in 15 October 2022.

Timeline
27 April 2022
Primary endpoint
27 September 2022
15 October 2022

Quick facts

Lead sponsorRiphah International University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment36
Start date27 April 2022
Primary completion27 September 2022
Estimated completion15 October 2022
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Riphah International University

Who can join

Adults 20 to 50, any sex, with Sacroiliac Joint Somatic Dysfunction or Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Sacroiliac joint dysfunction is the changing of joint structure (ligaments, muscles and cartilage) that cause impairments and movement restrictions. It is one of the primary sources of low back pain among female population and often misdiagnosed. Almost 15-30% patients are suffering from sacroiliac joint dysfunction who presented with the complaint of low back pain. The aim of the study is to determine the effect of mulligan's mobilization with and without clamshell exercise on pain, disability and quality of life in patients with sacroiliac joint dysfunction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Mulligan mobilization

Trials testing the same drug.

Other recruiting trials for Sacroiliac Joint Somatic Dysfunction

Currently open trials in the same condition.

Other Riphah International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05347537.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing